Clinical Trials Browser

ACTH Syndrome, Ectopic, Hyperaldosteronism

NCT07361874 2026-03-27

IMPACT-MACS

Phase NA Recruiting

75 enrolled

Adrenal incidentaloma, ACTH Syndrome, Ectopic, Cushing Syndrome, Insulin Resistance, Weight Loss

NCT07247058 2026-03-05

Isturisa Treatment in Mild Autonomous Cortisol Secretion( MACS)

Phase 4 Recruiting

10 enrolled

ACTH Syndrome, Ectopic, Adrenal Hyperplasia, Congenital, Hypertension

NCT07104812 2026-02-11

Impact of 1 mg Osilodrostat Therapy on Mild Autonomous Cortisol Secretion (MACS)

Phase 2 Recruiting

15 enrolled

ACTH Syndrome, Ectopic, Adrenal Hyperplasia, Congenital, Cushing Syndrome

NCT06106295 2025-09-22

Metyrapone for Mild Autonomous Cortisol Secretion (MACS)

Phase 2 Active not recruiting

30 enrolled

ACTH Syndrome, Ectopic, Adrenal Hyperplasia, Congenital, Cushing Syndrome

NCT07138274 2025-08-22

Metyrapone Study for Patients Diagnosed With Mild Autonomous Cortisol Secretion - MACS

Phase 2 Not yet recruiting

90 enrolled

ACTH Syndrome, Ectopic, Adrenal Hyperplasia, Congenital, Cushing Syndrome

NCT06576336 2024-08-28

3DAdrenal

Phase 4 Completed

350 enrolled

Endocrine

ACTH Syndrome, Ectopic, Adrenal Gland Neoplasms

NCT05839483 2023-07-17

CXCR4 Targeted PET Imaging in APA Preoperative Localization Diagnosis

Phase NA Unknown

50 enrolled

Endocrine

ACTH Syndrome, Ectopic, Hypertension, Hypokalemia, Adrenocortical Adenoma

NCT05607706 2022-11-07

Effect of Maternal Odor and Kangaroo Care on Serum Cortisol and Comfort Levels in Preterm Infants: a Randomised Trial

Phase NA Completed

92 enrolled

ACTH Syndrome, Ectopic, Premature Birth

NCT05361083 2022-05-04

First-in-human Evaluation of [18F]CETO

Phase EARLY_PHASE1 Completed

20 enrolled

Endocrine

ACTH Syndrome, Ectopic, Adrenocortical Carcinoma

NCT02780882 2018-01-26

SOM230 Ectopic ACTH-producing Tumors

Phase 2 Withdrawn

ACTH Syndrome, Ectopic

NCT02127840 2014-05-01

ISIRA

Phase 4 Unknown

40 enrolled

ACTH Syndrome, Ectopic, Hyperaldosteronism, Hypertension

Clinical Trials

ADERADHTA

IMPACT-MACS

Isturisa Treatment in Mild Autonomous Cortisol Secretion( MACS)

Impact of 1 mg Osilodrostat Therapy on Mild Autonomous Cortisol Secretion (MACS)

Metyrapone for Mild Autonomous Cortisol Secretion (MACS)

Metyrapone Study for Patients Diagnosed With Mild Autonomous Cortisol Secretion - MACS

3DAdrenal

CXCR4 Targeted PET Imaging in APA Preoperative Localization Diagnosis

Effect of Maternal Odor and Kangaroo Care on Serum Cortisol and Comfort Levels in Preterm Infants: a Randomised Trial

First-in-human Evaluation of [18F]CETO

SOM230 Ectopic ACTH-producing Tumors

ISIRA